ANNOVIS BIO: The Alzheimer's Disease Phase 3 clinical trial has completed enrollment of all participants; key data and declarations are expected to be completed in 2027.

Zhitongcaijing · 4d ago
ANNOVIS BIO: The Alzheimer's Disease Phase 3 clinical trial has completed enrollment of all participants; key data and declarations are expected to be completed in 2027.